{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:59:26Z","timestamp":1770764366248,"version":"3.50.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190704","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T18:35:24Z","timestamp":1519151724000},"page":"e0190704","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment"],"prefix":"10.1371","volume":"13","author":[{"given":"Yuan-Hong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":true,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"ref1","first-page":"760","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"I Milson","journal-title":"BJU Int 2001"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"KT McVary","year":"2011","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"M Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"JY Lee","year":"2004","journal-title":"BJU Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.urology.2007.03.063","article-title":"Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms","volume":"70","author":"HC Kuo","year":"2007","journal-title":"Urology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial","volume":"296","author":"SA Kaplan","year":"2006","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/nau.22645","article-title":"Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a \u03b23-adrenoceptor agonist, in patients with overactive bladder in Asia","volume":"34","author":"HC Kuo","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/nau.20923","article-title":"The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign prostatic hyperplasia","volume":"30","author":"SD Chung","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1742-1241.2011.02638.x","article-title":"Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms","volume":"65","author":"CH Liao","year":"2011","journal-title":"Int J Clin Pract"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000318568","article-title":"Does a pre-operative urodynamic diagnosis of bladder outflow obstruction improve outcomes from palliative transurethral prostatectomy?","volume":"86","author":"VJ Gnanapragasam","year":"2011","journal-title":"Urol Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000144049","article-title":"Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume","volume":"81","author":"CM Gomes","year":"2008","journal-title":"Urol Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000049784","article-title":"EAU guidelines on benign prostatic hyperplasia (BPH)","volume":"40","author":"JJ De la Rosette","year":"2001","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guidelines on the management of benign prostatic hyperplasia. Chapter 1. Diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1014457808748","article-title":"Symptoms and urodynamics after unsuccessful transurethral prostatectomy","volume":"32","author":"I Ignjatovic","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"ref15","first-page":"553","author":"A Cockett","year":"1993"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society","volume":"21","author":"P Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/luts.12067","article-title":"Role of bladder neck and urethral sphincter dysfunction in men with persistent bothersome lower urinary tract symptoms after alpha-1 blocker therapy","volume":"7","author":"QS Ke","year":"2015","journal-title":"Low Urin Tract Symptoms"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0090-4295(01)01413-3","article-title":"Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia","volume":"58","author":"MD Eckhardt","year":"2001","journal-title":"Urology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.299.6702.762","article-title":"Outcome of elective prostatectomy","volume":"299","author":"DE Neal","year":"1989","journal-title":"BMJ"},{"key":"ref20","first-page":"41","article-title":"Implications of prostatic volume measurements on the degree of bladder outlet obstruction in men with benign prostatic hyperplasia and lower urinary tract symptoms","volume":"17","author":"JL Chen","year":"2006","journal-title":"JUTA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000048427","article-title":"Analysis of pathophysiology of the lower urinary tract symptoms in patients after prostatectomy","volume":"68","author":"HC Kuo","year":"2002","journal-title":"Urol Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder","volume":"49","author":"CR Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11934-012-0265-x","article-title":"How do urodynamics findings influence the treatment of the typical patient with overactive bladder?","volume":"13","author":"MP Rutman","year":"2012","journal-title":"Curr Urol Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.urology.2015.01.028","article-title":"Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia","volume":"85","author":"T Maeda","year":"2015","journal-title":"Urology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2014.02.012","article-title":"Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony)","volume":"67","author":"P Abrams","year":"2015","journal-title":"Eur Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:10:08Z","timestamp":1589022608000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190704"}},"subtitle":[],"editor":[{"given":"Peter F.W.M.","family":"Rosier","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190704","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]}}}